Genetic counselling for hypertrophic cardiomyopathy: are we ready for it?
AUTOR(ES)
Vosberg, Hans-Peter
FONTE
BioMed Central
RESUMO
Hypertrophic cardiomyopathy (HCM) is a dominant genetic disorder of the myocardium associated with dysfunctional contractile proteins. The major risk of HCM is sudden cardiac death, which may occur even in asymptomatic carriers. Causes are highly heterogeneous. Over 140 different mutations in nine sarcomeric genes have been described to date. The majority of cases (80% or more) may eventually be traced to one of these genes. Although genetic counselling is suggested even if mutations are not known, molecular diagnosis implies new options such as carrier identification or - theoretically - preclinical risk stratification. A scheme according to which cardiologists and clinical and molecular geneticists could cooperate in counselling patients and managing HCM clinically is proposed.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=59597Documentos Relacionados
- Durable power of attorney for health care. Are we ready for it?
- Genetic investigation and counselling of families with hypertrophic cardiomyopathy.
- Hypertrophic cardiomyopathy: one disease or several?
- Noonan's cardiomyopathy: a non-hypertrophic variant.
- Genetic factors in familial hypertrophic cardiomyopathy: does molecular cardiology offer new perspectives?
